This special edition of the Small Cell SMASHERS features Misty Shields, MD, PhD, as a guest instead of her usual role as host. Dr. Shields is a thoracic medical oncologist, assistant professor of clinical medicine, adjunct assistant professor of medical and molecular genetics, and associate member of experimental and developmental therapeutics at Indiana University School of Medicine and Indiana University Health Physicians.
Dr. Shields discusses her American Society of Clinical Oncology (ASCO) Career Development Award study for lurbinectedin and the role of predictive biomarkers.
Moderated by Upal Basu Roy, PhD, MPH, LUNGevity’s Executive Director of Research, and Ann Fish-Steagall, LUNGevity’s SVP of Patient Services and Health Care Delivery, this monthly virtual series highlights the latest discoveries and breakthroughs for small cell lung cancer (SCLC).